doi: 10.3389/fcell.2016.00016 Received 29 November 2015 Accepted 22 February 2016 Published 23 March 2016 Volume 4 - 2016 Edited by Gaetano Santulli, Columbia University in the City of New York, USA Reviewed by Yves Combarnous, Centre National de la Recherche Scientifique, France
Siddiqui, I
Some medicines that should not be taken with methylene blue include: Certain medicines for depression or anxiety, including bupropion (Aplenzin, Forfivo, Wellbutrin), clomipramine (Anafranil), citalopram (Celexa), doxepin (Silenor), duloxetine (Cymbalta), escitalopram (Lexapro), fluoxetine (Prozac), fluvoxamine (Luvox), paroxetine (Paxil), sertraline (Zoloft), trazodone, and venlafaxine (Effexor) Monoamine oxidase inhibitors (MAOIs) for depression, such as isocarboxazid (Marplan), phenelzine (Nardil), and tranylcypromine (Parnate) Milnacipran (Savella), which treats fibromyalgia Mirtazapine (Remeron), a tetracyclic antidepressant Rasagiline (Azilect) and selegiline (Eldepryl, Emsam, Zelapar), Parkinsons disease treatments St
Supplementing with oral glutathione under conditions in which intracellular glutathione status is compromised can restore tissue glutathione and promote ROS metabolism, thereby mitigating tissue atrophy, according to a 2017 study published in the World Journal of Gastroenterology.
